AI and sustainability in the manufacturing industry

The integration of AI into the manufacturing industry promotes sustainability through real-time data analysis, predictive maintenance and intelligent control systems. These technologies help to conserve resources, reduce emissions and increase efficiency.

Generative AI in Market & Competitive Intelligence

Everyone is talking about generative AI and the business and trade press is full of articles about possible use cases, potential savings and the impact on the world of work.

A bit like the Starship Enterprise

Researchers at Stanford University together with colleagues at Harvard University in Cambridge, USA, have succeeded in printing 3D objects volumetrically in a stationary resin.

About early diagnosis, bioprinter proteins and electric fields

The basis of the patented technology is the so-called electrowetting effect. It describes the change in the surface tension of liquids when an electric field is applied.

Production of cable harnesses in the Ukraine

The wiring harnesses are complex components, some of which are individually manufactured for each vehicle model, which distribute the signals from sensors and control units.

Market for electrolyzers – the global race begins

In its "World Energy Transition Outlook 2022", the International Renewable Energy Agency (IRENA) predicts that the costs of electrolysers will fall by 2030 at a similar rate to that of solar panels and wind turbines.

Intel fulfilling Europe’s hunger for semiconductor chips

The shortage of semiconductor chips is a major issue disrupting the European supply chain. With the Chips Act, the European Union is looking for solutions to strengthen Europe's technological leadership while ensuring responsible sourcing.

Bioenergy from microalgae

Microalgae can reach lipid contents of up to 70 percent and starch contents of up to 60 percent. They grow considerably faster than land plants and require hardly any nutrients or pesticides.

10 years of experience CAR-T cell therapy

For around 10 years, leukemia patients have been treated with CAR T-cell therapy as a last resort. Patients are given genetically modified T cells that specifically recognize and eliminate the diseased cells with their antigen-specific receptors.

Targeted drug release: The microswimmers are loose

A hitherto unsolved problem in cancer therapy: How can the diseased cells be targeted without damaging the good ones? If the active substances could be administered specifically at the "crime scene", not only could the dose be reduced, but the collateral damage could also be minimized.